Last reviewed · How we verify
NCT03025165
A Comparison of Different Community Models of ART Delivery Amongst Stable HIV+ Patients in Two Urban Settings in Zambia
NA trial testing Community Adherence Clubs in HIV Infections in 2,526 participants. Completed in 22 July 2019.
22 July 2019
Quick facts
| Lead sponsor | HIV Prevention Trials Network |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2,526 |
| Start date | 1 May 2017 |
| Primary completion | 22 July 2019 |
| Estimated completion | 22 July 2019 |
| Sites | 1 location across Zambia |
Drugs / interventions tested
- Community Adherence Clubs
- Home-Based ART Delivery
- Standard of Care
Conditions studied
- HIV Infections — all drugs for HIV Infections →
Sponsor
HIV Prevention Trials Network
Who can join
18 and older, any sex, with HIV Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare the virological and clinical outcomes of patients participating in community models of ART delivery to the standard of care in an urban setting in Zambia.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial.
Limbada M, Macleod D, Situmbeko V, Muhau E, et al · · 2022 · cited 13× · PMID 34843674 · DOI 10.1016/s2352-3018(21)00242-3 -
A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV+ patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study.
Limbada M, Bwalya C, Macleod D, Floyd S, et al · · 2021 · cited 6× · PMID 33430928 · DOI 10.1186/s13063-020-05010-w
Verify or expand the search:
- PubMed search for NCT03025165
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HIV Infections
Currently open trials in the same condition.
- NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
- NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
- NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
- NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
- NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting
Other HIV Prevention Trials Network trials
Trials by the same sponsor.
- NCT07288190 — Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR · Phase 2 · not yet recruiting
- NCT05075967 — Getting to Zero Among HHI MSM in the American South · NA · enrolling by invitation
- NCT06200545 — Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi · NA · completed
- NCT06148584 — Testing a Barbershop-based HIV Prevention Initiative Among Men · NA · completed
- NCT04804072 — INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03025165 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HIV Prevention Trials Network
- Last refreshed: 25 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03025165.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing